Description

PRESTIGE® WNV has been shown to be effective for the vaccination of healthy horses 6 months of age or older against West Nile Virus.  This product has been shown to be effective against encephalitis and viremia caused by West Nile Virus.
•        Use prior to mosquito season; generally spring (depending on region of country)
•        Exceptional safety profile with Havlogen® adjuvant and Antigen Purification System™     
•        West Nile virus is a core vaccine, recommended by AAEP for all horses, every year1

1 AAEP Core Vaccine Guidelines (aaep.org)

CAUTIONS:

Store at 2°-8°C (35°-46°F). Shake well before using. Use entire contents when first opened. Do not mix with other products. This product has not been tested in pregnant animals. Do not vaccinate within 21 days before slaughter. Inject deep into the muscle only. Local reactions may occur at the injection sites in vaccinates, and most of these reactions resolve in 3 to 7 days following vaccination. Systemic reactions may also occur in animals following vaccination. If allergic reaction occurs, treat with epinephrine. Care should be used to avoid injecting your own fingers, hands, or other body parts. Accidental injection can cause serious local reactions. In case of human exposure, contact a physician.


Prestige WNV is a registered trademark of Intervet Inc., d/b/a Merck Animal Health, a subsidiary of Merck & Co. Inc.